What are the first‑line treatment recommendations for post‑traumatic stress disorder, including psychotherapy and pharmacotherapy?

Treatment for PTSD

For chronic PTSD, trauma-focused cognitive behavioral therapy—specifically prolonged exposure, cognitive processing therapy, or eye movement desensitization and reprocessing (EMDR)—is the first-line treatment, with SSRIs (sertraline or paroxetine) as second-line or adjunctive options. 1, 2

First-Line Psychotherapy

Trauma-focused CBT variants are strongly recommended as initial treatment:

• Prolonged exposure therapy has the greatest empirical support across the widest range of trauma populations and has been successfully disseminated to community clinics 1
• Cognitive processing therapy is strongly recommended with robust evidence for PTSD symptom reduction 1, 3
• Eye movement desensitization and reprocessing (EMDR) is strongly recommended, though it has been studied less extensively than the other two 1, 3

These psychotherapies demonstrate superior long-term outcomes compared to medications, with significantly lower relapse rates upon treatment discontinuation 1

Important caveat: Despite proven efficacy, many therapists are not trained in or are reluctant to use exposure therapy, creating a significant implementation gap 1. Secure video teleconferencing can deliver these therapies when validated for that modality or when in-person options are unavailable 1

First-Line Pharmacotherapy

When psychotherapy is unavailable or as adjunctive treatment:

• Sertraline and paroxetine are the only FDA-approved medications for PTSD and are recommended as first-line pharmacological options 1
• Venlafaxine (an SNRI) is also recommended, though it shows no benefit for hyperarousal symptoms specifically 1, 4

Critical limitation: Medication discontinuation is associated with significant relapse rates, unlike CBT where treatment gains are maintained 1

Treatments to Avoid

The following are strongly recommended against:

• Benzodiazepines: Not only ineffective for prevention, but one study found 63% of those receiving benzodiazepines developed PTSD at 6 months compared to 23% receiving placebo 1
• Cannabis or cannabis-derived products: Insufficient evidence and potential for harm 1
• Psychological debriefing: Despite widespread dissemination and high consumer satisfaction, randomized controlled trials do not support its usefulness in preventing chronic stress reactions 1

Treatment Algorithm by Clinical Scenario

For Acute Stress (2-5 weeks post-trauma):

• Brief CBT (4-5 sessions) for individuals with high post-traumatic stress symptoms accelerates recovery and may prevent chronic PTSD 1
• Early medication (benzodiazepines, propranolol, hydrocortisone) has been found to be of limited benefit 1

For Chronic PTSD with Prominent Nightmares:

Start with prazosin as first-line for sleep impairment:

• Begin at 1 mg at bedtime, increase by 1-2 mg every few days to effective dose (average ~3 mg, range 1-13 mg) 1, 4
• Monitor for orthostatic hypotension 1
• Level A recommendation for PTSD-associated nightmares 1

After addressing sleep, if daytime symptoms persist:

• Add an SSRI (sertraline or paroxetine) 4
• Image rehearsal therapy (IRT) is also Level A recommended for nightmare disorder 1

For Complex PTSD:

Contrary to older expert consensus, recent evidence does not support mandatory stabilization phases:

• The 2016 critical analysis found that trauma-focused therapy can be provided directly without prior stabilization, even in vulnerable populations with childhood abuse histories and severe comorbidity 1
• The assumption that patients with complex PTSD cannot tolerate trauma-focused interventions is not supported by current evidence 1

Augmentation Strategies

If SSRI monotherapy is insufficient:

• Consider augmentation with aripiprazole, particularly if psychotic symptoms are present 4
• A second SSRI or switching to venlafaxine may be tried, though venlafaxine offers no benefit for hyperarousal symptoms 4
• Prazosin can be added for residual daytime symptoms beyond nightmares 4

Common Pitfalls

Avoid these errors:

• Providing psychological debriefing within 24-72 hours post-trauma—it does not prevent chronic PTSD despite widespread use 1
• Using benzodiazepines for acute stress reactions—they may actually increase PTSD risk 1
• Delaying trauma-focused therapy in favor of prolonged stabilization for complex presentations—direct trauma-focused treatment is effective and safe 1
• Discontinuing effective psychotherapy prematurely—CBT gains are maintained long-term, unlike medications 1